The evolution of the psychedelic revolution
Neuropsychopharmacology
.
2022 Jan;47(1):413-414.
doi: 10.1038/s41386-021-01150-y.
Authors
Lindsay P Cameron
1
,
David E Olson
2
3
4
Affiliations
1
Neuroscience Graduate Program, University of California, Davis, Davis, CA, USA.
2
Department of Chemistry, University of California, Davis, Davis, CA, USA. deolson@ucdavis.edu.
3
Department of Biochemistry & Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA. deolson@ucdavis.edu.
4
Center for Neuroscience, University of California, Davis, Davis, CA, USA. deolson@ucdavis.edu.
PMID:
34400786
PMCID:
PMC8616895
DOI:
10.1038/s41386-021-01150-y
No abstract available
Publication types
News
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Hallucinogens* / pharmacology
Lysergic Acid Diethylamide
Substances
Hallucinogens
Lysergic Acid Diethylamide
Grants and funding
R01 GM128997/GM/NIGMS NIH HHS/United States
T32 MH112507/MH/NIMH NIH HHS/United States